The Finnish Research Impact Foundation awarded Professor Riitta Lahesmaa €224,639 in funding
The Finnish Research Impact Foundation awarded Professor Riitta Lahesmaa €224,639 in funding for a project that explores a treatment of cancer which utilizes body’s own immune defense system. Lahesmaa is the Director of the Turku Bioscience Center and InFLAMES flagship group leader. The research is conducted in cooperation with Orion Pharma.
Read the full article in Finnish
Recent Posts
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- Early-career researchers invited to BioCity Pre-Symposium on 26 August.Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026.This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026